Correction.
- Published in:
- 2023
- Publication type:
- Correction Notice
Works matching IS 00912700 AND DT 2023 AND VI 63 AND IP 6
Results: 15
1
2
In Memoriam.
- Published in:
- 2023
- By:
- Publication type:
- Obituary
3
Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 640, doi. 10.1002/jcph.2209
- By:
- Publication type:
- Article
4
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing Information.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 695, doi. 10.1002/jcph.2208
- By:
- Publication type:
- Article
5
Stevens–Johnson Syndrome in an Adult Filipino Male Positive for HLA‐B*38:16 and B*58:17, Associated With Allopurinol: A Case Report.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
6
Revisiting Old Drugs Owing to the Glymphatic System: A Step Toward Unlocking the Role of Hypnotics in Brain Health.
- Published in:
- 2023
- By:
- Publication type:
- Lesson Plan
7
Population Pharmacokinetics and Exposure‐Response Modeling Analyses of Golimumab in Children and Young Adults With Recently Diagnosed Type 1 Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 721, doi. 10.1002/jcph.2217
- By:
- Publication type:
- Article
8
Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 732, doi. 10.1002/jcph.2214
- By:
- Publication type:
- Article
9
In Silico Re‐Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure–Response Simulation.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 672, doi. 10.1002/jcph.2203
- By:
- Publication type:
- Article
10
Population Pharmacokinetics, Exposure–Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep‐Seated Mycoses.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 704, doi. 10.1002/jcph.2212
- By:
- Publication type:
- Article
11
Effectiveness of Sufentanil‐Based Patient‐Controlled Analgesia Regimen in Children and Incidence of Adverse Events Following Major Congenital Structure Repairs.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 715, doi. 10.1002/jcph.2211
- By:
- Publication type:
- Article
12
Low Early Antifactor Xa Target Achievement Rate of Low‐Molecular‐Weight Heparin for Treating Venous Thromboembolism in Patients in Intensive Care.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 664, doi. 10.1002/jcph.2210
- By:
- Publication type:
- Article
13
Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 681, doi. 10.1002/jcph.2205
- By:
- Publication type:
- Article
14
Issue Information.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 633, doi. 10.1002/jcph.1900
- Publication type:
- Article
15
Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5‐Year Retrospective Cohort Study.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 6, p. 654, doi. 10.1002/jcph.2204
- By:
- Publication type:
- Article